These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 17721276)

  • 1. Comparison of the Dako EGFR pharmDx kit and Zymed EGFR antibody for assessment of EGFR status in colorectal adenocarcinoma.
    Buckley AF; Kakar S
    Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):305-9. PubMed ID: 17721276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.
    Lee HJ; Xu X; Choe G; Chung DH; Seo JW; Lee JH; Lee CT; Jheon S; Sung SW; Chung JH
    Lung Cancer; 2010 Jun; 68(3):375-82. PubMed ID: 19712993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa.
    Bhargava R; Chen B; Klimstra DS; Saltz LB; Hedvat C; Tang LH; Gerald W; Teruya-Feldstein J; Paty PB; Qin J; Shia J
    Cancer; 2006 Apr; 106(8):1857-62. PubMed ID: 16532444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there an immunohistochemical technique definitively valid in epidermal growth factor receptor assessment?
    Penault-Llorca F; Cayre A; Arnould L; Bibeau F; Bralet MP; Rochaix P; Savary J; Sabourin JC
    Oncol Rep; 2006 Dec; 16(6):1173-9. PubMed ID: 17089034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancer.
    Hirsch FR; Dziadziuszko R; Thatcher N; Mann H; Watkins C; Parums DV; Speake G; Holloway B; Bunn PA; Franklin WA
    Cancer; 2008 Mar; 112(5):1114-21. PubMed ID: 18219661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of four antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in non-small cell lung cancer.
    Mathieu A; Weynand B; Verbeken E; Da Silva S; Decaestecker C; Salmon I; Demetter P
    Lung Cancer; 2010 Jul; 69(1):46-50. PubMed ID: 19796839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.
    Scartozzi M; Bearzi I; Berardi R; Mandolesi A; Fabris G; Cascinu S
    J Clin Oncol; 2004 Dec; 22(23):4772-8. PubMed ID: 15570078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of EGFR PharmDx kit for cetuximab eligibility.
    Ensinger C; Sterlacci W
    Expert Rev Mol Diagn; 2008 Mar; 8(2):141-8. PubMed ID: 18366301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel EGFR mutation-specific antibodies for lung adenocarcinoma: highly specific but not sensitive detection of an E746_A750 deletion in exon 19 and an L858R mutation in exon 21 by immunohistochemistry.
    Seo AN; Park TI; Jin Y; Sun PL; Kim H; Chang H; Chung JH
    Lung Cancer; 2014 Mar; 83(3):316-23. PubMed ID: 24412618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR-immunohistochemistry in colorectal cancer and non-small cell lung cancer: comparison of 3 commercially available EGFR-antibodies.
    Buffet W; Geboes KP; Dehertogh G; Geboes K
    Acta Gastroenterol Belg; 2008; 71(2):213-8. PubMed ID: 18720932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.
    Wong SF
    Clin Ther; 2005 Jun; 27(6):684-94. PubMed ID: 16117976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor gene promoter methylation in primary colorectal tumors and corresponding metastatic sites: a new perspective for an "old" therapeutic target.
    Scartozzi M; Bearzi I; Mandolesi A; Galizia E; Pierantoni C; Loupakis F; Berardi R; Zaniboni A; Quadri A; Zorzi F; Biagetti S; Loretelli C; Biscotti T; Labianca R; Masi G; Falcone A; Cascinu S
    Anal Quant Cytol Histol; 2009 Dec; 31(6):417-23. PubMed ID: 20698358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor analyses in colorectal cancer: a comparison of methods.
    Spindler KL; Lindebjerg J; Nielsen JN; Olsen DA; Bisgård C; Brandslund I; Jakobsen A
    Int J Oncol; 2006 Nov; 29(5):1159-65. PubMed ID: 17016647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity epidermal growth factor receptor immunostaining for colorectal carcinomas, compared with EGFR PharmDx™: a study of diagnostic accuracy.
    Shiogama K; Wongsiri T; Mizutani Y; Inada K; Tsutsumi Y
    Int J Clin Exp Pathol; 2013; 6(1):24-30. PubMed ID: 23236539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR fluorescence in situ hybridization pattern of chromosome 7 disomy predicts resistance to cetuximab in KRAS wild-type metastatic colorectal cancer patients.
    Li YH; Wang F; Shen L; Deng YM; Shao Q; Feng F; An X; Wang FH; Wang ZQ; Xu RH; Shao JY
    Clin Cancer Res; 2011 Jan; 17(2):382-90. PubMed ID: 20884623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarray.
    Bibeau F; Boissière-Michot F; Sabourin JC; Gourgou-Bourgade S; Radal M; Penault-Llorca F; Rochaix P; Arnould L; Bralet MP; Azria D; Ychou M
    Virchows Arch; 2006 Sep; 449(3):281-7. PubMed ID: 16865406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal Growth Factor Receptor Inconsistency by Immunohistochemistry Method Using Different Monoclonal Antibodies in Colorectal Cancer Patients.
    Fan CC; Wang TY; Kung CM
    Clin Lab; 2015; 61(11):1635-41. PubMed ID: 26731987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of epidermal growth factor receptor in primary colorectal adenocarcinoma predicts expression in recurrent disease.
    Khalifa MA; Rowsell CH; Gladdy RA; Ko YJ; Hanna S; Smith A; Law C
    Am J Clin Pathol; 2006 Feb; 125(2):229-33. PubMed ID: 16393679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor.
    Goetz M; Ziebart A; Foersch S; Vieth M; Waldner MJ; Delaney P; Galle PR; Neurath MF; Kiesslich R
    Gastroenterology; 2010 Feb; 138(2):435-46. PubMed ID: 19852961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.